binding affinity News and Research

RSS
N501Y mutation and SARS-CoV-2 spike protein-angiotensin-converting enzyme-2 binding

N501Y mutation and SARS-CoV-2 spike protein-angiotensin-converting enzyme-2 binding

1 Sep 2022
The effects of amino acid substitutions on the affinity of the SARS-CoV-2 spike RBD to the human receptor hACE2

The effects of amino acid substitutions on the affinity of the SARS-CoV-2 spike RBD to the human receptor hACE2

30 Aug 2022
Researchers report the exceptional binding and neutralizing potency of an ACE2 decoy against SARS-CoV-2 variants

Researchers report the exceptional binding and neutralizing potency of an ACE2 decoy against SARS-CoV-2 variants

30 Aug 2022
Researchers report large molecular compounds and nanoscale nanozyme of two traditional Chinese medicines may inhibit COVID-19 signaling

Researchers report large molecular compounds and nanoscale nanozyme of two traditional Chinese medicines may inhibit COVID-19 signaling

25 Aug 2022
Virtual screening and molecular dynamics explore potential repurposed drugs against monkeypox virus

Virtual screening and molecular dynamics explore potential repurposed drugs against monkeypox virus

25 Aug 2022
What is the impact of a syntenin inhibitor in COVID-19 treatment?

What is the impact of a syntenin inhibitor in COVID-19 treatment?

24 Aug 2022
How effective are nanotechnology-based vaccines, drugs, and antibodies to combat variants of SARS-CoV-2?

How effective are nanotechnology-based vaccines, drugs, and antibodies to combat variants of SARS-CoV-2?

22 Aug 2022
Rapid and efficient strategy for the development and design of SARS-CoV-2 neutralizing humanized nanobody constructs

Rapid and efficient strategy for the development and design of SARS-CoV-2 neutralizing humanized nanobody constructs

16 Aug 2022
A non-covalent inhibitor of 3C-like protease effectively inhibits SARS-CoV-2 replication

A non-covalent inhibitor of 3C-like protease effectively inhibits SARS-CoV-2 replication

16 Aug 2022
Mechanistic insights into engineered ACE2 receptor traps

Mechanistic insights into engineered ACE2 receptor traps

12 Aug 2022
Bispecific antibody exhibits high breadth and potency against SARS-CoV-2 Omicron sub-lineages

Bispecific antibody exhibits high breadth and potency against SARS-CoV-2 Omicron sub-lineages

12 Aug 2022
The features of the newly emerging SARS-CoV-2 Omicron BA.2.75 subvariant

The features of the newly emerging SARS-CoV-2 Omicron BA.2.75 subvariant

10 Aug 2022
Researchers create a physical wiring diagram of the human immune system

Researchers create a physical wiring diagram of the human immune system

8 Aug 2022
The antibody evasion properties of the SARS-CoV-2 Omicron subvariant BA.2.75

The antibody evasion properties of the SARS-CoV-2 Omicron subvariant BA.2.75

3 Aug 2022
Hemopurifier containing Galanthus nivalis resin removes SARS-CoV-2 variants

Hemopurifier containing Galanthus nivalis resin removes SARS-CoV-2 variants

2 Aug 2022
Decoy ACE2 receptors broadly neutralize SARS-CoV-2 variants

Decoy ACE2 receptors broadly neutralize SARS-CoV-2 variants

31 Jul 2022
The global mutation landscape of the SARS-CoV-2 non-structural protein 1

The global mutation landscape of the SARS-CoV-2 non-structural protein 1

28 Jul 2022
The identification and characterization of an anti-SARS-CoV-2 monoclonal antibody with superior breadth and potency

The identification and characterization of an anti-SARS-CoV-2 monoclonal antibody with superior breadth and potency

28 Jul 2022
Novel compound inhibits SARS-CoV-2 replication by binding a genome target

Novel compound inhibits SARS-CoV-2 replication by binding a genome target

27 Jul 2022
How has vaccination shaped the global evolutionary trajectory of SARS-CoV-2?

How has vaccination shaped the global evolutionary trajectory of SARS-CoV-2?

26 Jul 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback